Purchase Order 75N95024P00175
Award Date 3/8/24
Potential Completion Date 5/3/24
Potential Value $126K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed-price purchase order contract to Covaris, Inc., a for-profit limited liability company, for the acquisition of an E220 Focused UltraSonicator with water conditioning system and chiller. The total potential value of the contract is $120,935.00. The contract did not have a set-aside designation. According to the pre-solicitation notice, the Covaris E220...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Covaris, LLC, a for-profit manufacturer of advanced genomic research tools and technologies. The contract, valued at $112,351.00, is for the provision of an R230 focused ultrasonicator and accessories. The contract has no set-aside designation. Covaris, LLC is a prominent supplier of ultrasonicator instruments, sample preparation equipment, and...
- Covaris, LLC, a Woburn, Massachusetts-based small business specializing in advanced genomic research equipment, was awarded a $17,346 firm-fixed-price purchase order by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health. The contract, issued on December 22, 2025, carries an ultimate completion date of December 21, 2026, and involves no set-aside designation. Covaris is a well-established manufacturer of ultrasonicator instruments utilizing...
- This firm-fixed-price purchase order valued at $4,500 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic sample preparation instruments and accessories. The contract, which had no set-aside designation, was for the delivery of Covaris' ME220, M220, and LE220-plus focused-ultrasonicator systems and related maintenance services to support genomic...
- This is a $52,055 firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of genomic research equipment. The contract is for the delivery of Covaris' ultrasonicator instruments, accessories, and related maintenance services to support advanced DNA and RNA sample preparation for NIH's scientific initiatives. Covaris has previously received other direct federal...
- This firm-fixed-price purchase order contract was awarded to Covaris, LLC, a for-profit manufacturer of advanced genomics tools and technologies, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $28,185.00, is for the upgrade of ultrasonicator systems used to support NIAID's genomic research initiatives. Covaris, which has extensive experience providing equipment and maintenance services to...
- This firm-fixed-price purchase order from the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded Covaris, LLC $181,340.00 to upgrade and expand their ultrasonicator systems. Covaris is a for-profit manufacturer of genomics equipment and services, and has received numerous NIH and other federal agency contracts to supply focused-ultrasonicator instruments, accessories, and maintenance. This award did not have a small business set-aside...
- Covaris, LLC has been awarded a firm fixed-price purchase order totaling $13,152 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver an Automated Dry Pulverizer Extraction System. As the industry leader in tools and technologies for DNA and RNA shearing and other genomic applications, Covaris will provide the requested laboratory equipment to support the NIH institute's research efforts. No set-aside was designated for this award to the...
- This contract award to Covaris, LLC provides a single-sample processing ultrasonicator with a laptop computer to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $46,125 firm-fixed-price purchase order does not have a set-aside designation. Covaris, a for-profit manufacturer of genomic tools and technologies, has received numerous federal contract awards from NIH and other agencies like the USDA and VA to supply...
- This is a $47,300.00 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic research equipment and accessories. The contract is for the delivery of Covaris' desktop focused-ultrasonicator instruments, such as the ME220, M220, and LE220-plus models, as well as related maintenance services. This award does not have...
Covaris, LLC was awarded a firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences for the delivery of a Covaris R230 Focused-Ultrasonicator. With a potential value of $125,580, this sole source contract has no set aside designation and calls for the prime contractor to provide the specified equipment to the agency by May 3, 2024. As the industry leader in tools and technologies for DNA and RNA shearing and other genomic applications, Covaris will leverage its expertise to support the National Center for Advancing Translational Sciences' mission to develop innovative methods and therapies and speed the translation of laboratory discoveries into clinical practice.
Generated 3/8/24, 10:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $125.6k | 3/7/24 |